Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients

Authors: Lena Peter, Désirée Jacqueline Wendering, Stephan Schlickeiser, Henrike Hoffmann, Rebecca Noster, Dimitrios Laurin Wagner, Ghazaleh Zarrinrad, Sandra Münch, Samira Picht, Sarah Schulenberg, Hanieh Moradian, Mir-Farzin Mashreghi, Oliver Klein, Manfred Gossen, Toralf Roch, Nina Babel, Petra Reinke, Hans-Dieter Volk, Leila Amini, Michael Schmueck-Henneresse

Source: Molecular Therapy: Methods & Clinical Development, Vol 25, Iss , Pp 52-73 (2022)

Subject Terms: solid organ transplant recipients, SARS-CoV-2 infection, COVID-19, adoptive immunotherapy, T cell therapy, CRISPR-Cas9, Genetics, QH426-470, Cytology, QH573-671

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2329050122000286; https://doaj.org/toc/2329-0501

Access URL: https://doaj.org/article/9113c01efc2341409d18184065607cd5